Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes

Journal of Hepatology

Volumn 40, Issue 6, 2004, Pages 963-970

  Fernández Martínez, Amalia ^a   Callejas, Nuria A ^a   Casado, Marta ^b   Boscá, Lisardo ^a   Martín Sanz, Paloma ^a  

^a CSIC   (Spain)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

Cell cycle; Hepatotoxicity; Inflammation; Liver regeneration; Nitric oxide; Prostaglandins

Indexed keywords

BIOLOGICAL MARKER; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN D1; CYCLIN E; CYCLINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; GENE EXPRESSION; GENE FUNCTION; INFLAMMATION; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; LIVER REGENERATION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL;

ANIMALS; CAENORHABDITIS ELEGANS PROTEINS; CARCINOGENS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GENE DELETION; HEPATOCYTES; LIVER; LIVER FUNCTION TESTS; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOACETAMIDE;

EID: 2442663797     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(04)00086-8     Document Type: Article

References (48)

1. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 88:1991;2692-2696
2. DeWitt D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta. 1083:1991;121-134
3. Pilbeam C.C., Kawaguchi H., Hakeda Y., Voznesensky O., Alander C.B., Raisz L.G. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem. 268:1993;25643-25649
4. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 266:1991;12866-12872
5. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 95:1995;1669-1675
6. Herschman H.R., Gilbert R.S., Xie W., Luner S., Reddy S.T. The regulation and role of TIS10 prostaglandin synthase-2. Adv Prostaglandin Thromboxane Leukot Res. 23:1995;23-28
7. Zhang F., Warskulat U., Wettstein M., Schreiber R., Henninger H.P., Decker K., et al. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem J. 312:1995;135-143
8. Nanji A.A., Miao L., Thomas P., Rahemtulla A., Khwaja S., Zhao S., et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology. 112:1997;943-951
9. Ledwith B.J., Pauley C.J., Wagner L.K., Rokos C.L., Alberts D.W., Manam S. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12, 13-myristate-type tumor promoters in immortalized mouse liver cells. J Biol Chem. 272:1997;3707-3714
10. Callejas N.A., Bosca L., Williams C.S., Dubois R.N., Martin-Sanz P. Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer- binding proteins. Gastroenterology. 119:2000;493-501
11. Casado M., Callejas N.A., Rodrigo J., Zhao X., Dey S.K., Bosca L., et al. Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J. 15:2001;2016-2018
12. Hortelano S., Dewez B., Genaro A.M., Diaz-Guerra M.J., Bosca L. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology. 21:1995;776-786
13. Diaz-Guerra M.J., Velasco M., Martin-Sanz P., Bosca L. Nuclear factor κB is required for the transcriptional control of type II NO synthase in regenerating liver. Biochem J. 326:1997;791-797
14. Rai R.M., Lee F.Y., Rosen A., Yang S.Q., Lin H.Z., Koteish A., et al. Impaired liver regeneration in inducible nitric oxide synthase deficient mice. Proc Natl Acad Sci USA. 95:1998;13829-13834
15. Diez-Fernandez C., Bosca L., Fernandez-Simon L., Alvarez A., Cascales M. Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide. Hepatology. 18:1993;912-918
16. Mangipudy R.S., Chanda S., Mehendale H.M. Hepatocellular regeneration: key to thioacetamide autoprotection. Pharmacol Toxicol. 77:1995;182-188
17. Mojena M., Hortelano S., Castrillo A., Diaz-Guerra M.J., Garcia-Barchino M.J., Saez G.T., et al. Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene. FASEB J. 15:2001;583-585
18. Sanz N., Diez-Fernandez C., Alvarez A.M., Fernandez-Simon L., Cascales M. Age-related changes on parameters of experimentally-induced liver injury and regeneration. Toxicol Appl Pharmacol. 154:1999;40-49
19. Riendeau D., Percival M.D., Boyce S., Brideau C., Charleson S., Cromlish W., et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 121:1997;105-117
20. Sirois J., Levy L.O., Simmons D.L., Richards J.S. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions. J Biol Chem. 268:1993;12199-12206
21. Castrillo A., Diaz-Guerra M.J., Hortelano S., Martin-Sanz P., Bosca L. Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-Delta(12, 14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol. 20:2000;1692-1698
22. Martin-Sanz P., Cascales C., Gomez A., Brindley D.N., Cascales M. Effect of a rhodium complex on alterations of hepatic function in thioacetamide-induced hyperplastic noduligenesis in rats. Carcinogenesis. 8:1987;1685-1690
23. Diez-Fernandez C., Sanz N., Bosca L., Hortelano S., Cascales M. Involvement of nitric oxide synthesis in hepatic perturbations induced in rats by a necrogenic dose of thioacetamide. Br J Pharmacol. 121:1997;820-826
24. Diez-Fernandez C., Sanz N., Cascales M. Intracellular calcium concentration impairment in hepatocytes from thioacetamide-treated rats. Implications for the activity of Ca(2+)-dependent enzymes. J Hepatol. 24:1996;460-467
25. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., et al. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073
26. Liu C.H., Chang S.H., Narko K., Trifan O.C., Wu M.T., Smith E., et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem. 276:2001;18563-18569
27. Ryseck R.P., Raynoschek C., Macdonald-Bravo H., Dorfman K., Mattei M.G., Bravo R. Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ. 3:1992;443-450
28. Morinaga S., Yamamoto Y., Noguchi Y., Imada T., Rino Y., Akaike M., et al. Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma. J Gastroenterol Hepatol. 17:2002;1110-1116
29. Williams C.S., Dubois R.N. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol. 270:1996;G393-G400
30. Bae S.H., Jung E.S., Park Y.M., Kim B.S., Kim B.K., Kim D.G., et al. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res. 7:2001;1410-1418
31. Begay C.K., Gandolfi A.J. Late administration of COX-2 inhibitors minimize hepatic necrosis in chloroform induced liver injury. Toxicology. 185:2003;79-87
32. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun. 254:1999;764-767
33. Yamamoto H., Kondo M., Nakamori S., Nagano H., Wakasa K., Sugita Y., et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Gastroenterology. 125:2003;556-571
34. Reilly T.P., Brady J.N., Marchick M.R., Bourdi M., George J.W., Radonovich M.F., et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol. 14:2001;1620-1628
35. Kassahun K., McIntosh I.S., Shou M., Walsh D.J., Rodeheffer C., Slaughter D.E., et al. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. Drug Metab Dispos. 29:2001;813-820
36. Yergey J.A., Trimble L.A., Silva J., Chauret N., Li C., Therien M., et al. In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization. Drug Metab Dispos. 29:2001;638-644
37. Bulera S.J., Eddy S.M., Ferguson E., Jatkoe T.A., Reindel J.F., Bleavins M.R., et al. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology. 33:2001;1239-1258
38. Bourdi M., Masubuchi Y., Reilly T.P., Amouzadeh H.R., Martin J.L., George J.W., et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology. 35:2002;289-298
39. Michael S.L., Mayeux P.R., Bucci T.J., Warbritton A.R., Irwin L.K., Pumford N.R., et al. Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity. Nitric Oxide. 5:2001;432-441
40. Diez-Fernandez C., Sanz N., Alvarez A.M., Zaragoza A., Cascales M. Influence of aminoguanidine on parameters of liver injury and regeneration induced in rats by a necrogenic dose of thioacetamide. Br J Pharmacol. 125:1998;102-108
41. Harstad E.B., Klaassen C.D. iNOS-null mice are not resistant to cadmium chloride-induced hepatotoxicity. Toxicology. 175:2002;83-90
42. Chu C.J., Wang S.S., Lee F.Y., Chang F.Y., Lin H.C., Hou M.C., et al. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure. Eur J Clin Invest. 31:2001;156-163
43. Diehl A.M. Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. J Biol Chem. 273:1998;30843-30846
44. Hendricks-Taylor L.R., Darlington G.J. Inhibition of cell proliferation by C/EBP α occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res. 23:1995;4726-4733
45. Chen P.L., Riley D.J., Chen Y., Lee W.H. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:1996;2794-2804
46. Kramer A., Carstens C.P., Fahl W.E. A novel CCAAT-binding protein necessary for adhesion-dependent cyclin A transcription at the G1/S boundary is sequestered by a retinoblastoma-like protein in G0. J Biol Chem. 271:1996;6579-6582
47. Zhao G., Nakano K., Chijiiwa K., Ueda J., Tanaka M. Inhibited activities in CCAAT/enhancer-binding protein, activating protein-1 and cyclins after hepatectomy in rats with thioacetamide-induced liver cirrhosis. Biochem Biophys Res Commun. 292:2002;474-481
48. Jeong D.H., Jang J.J., Lee S.J., Lee J.H., Lim I.K., Lee M.J., et al. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. J Gastroenterol. 36:2001;24-32